News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
107,769 Results
Type
Article (4250)
Company Profile (18)
Press Release (103501)
Section
Business (31968)
Career Advice (108)
Deals (5249)
Drug Delivery (5)
Drug Development (5402)
Employer Resources (11)
FDA (3199)
Job Trends (2076)
News (46951)
Policy (3872)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (363)
Allergies (9)
Alliances (11159)
ALS (6)
Alzheimer's disease (308)
Antibody-drug conjugate (ADC) (3)
Approvals (3209)
Artificial intelligence (84)
Automation (3)
Bankruptcy (46)
Best Places to Work (1718)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (9)
Brain cancer (5)
Breast cancer (56)
Cancer (388)
Cardiovascular disease (24)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (22)
Cervical cancer (7)
Clinical research (4175)
Collaboration (164)
Compensation (16)
COVID-19 (479)
C-suite (34)
Cystic fibrosis (8)
Data (232)
Decentralized trials (1)
Depression (4)
Diabetes (16)
Diagnostics (5791)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (13)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10434)
Employer branding (2)
Employer resources (11)
Events (13500)
Executive appointments (102)
FDA (3373)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (120)
Gene editing (1)
Generative AI (8)
Gene therapy (13)
GLP-1 (40)
Government (624)
Guidances (5)
Healthcare (2908)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (2)
Infectious disease (505)
Inflammatory bowel disease (12)
Influenza (10)
Intellectual property (6)
Interviews (12)
IPO (1796)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (4)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (534)
Liver cancer (11)
Lung cancer (45)
Lymphoma (28)
Machine learning (1)
Management (3)
Manufacturing (42)
MASH (4)
Medical device (2454)
Medtech (2454)
Mergers & acquisitions (3534)
Metabolic disorders (33)
Multiple sclerosis (18)
NASH (3)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (361)
NextGen: Class of 2025 (703)
Non-profit (546)
Northern California (328)
Now hiring (2)
Obesity (13)
Opinion (11)
Ovarian cancer (13)
Pain (3)
Pancreatic cancer (10)
Parkinson's disease (14)
Partnered (3)
Patents (19)
Patient recruitment (9)
Peanut (4)
People (8956)
Pharmaceutical (1)
Phase I (1261)
Phase II (1751)
Phase III (1602)
Pipeline (115)
Podcasts (1)
Policy (1)
Postmarket research (212)
Preclinical (591)
Press Release (11)
Prostate cancer (33)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (28)
Real estate (861)
Recruiting (5)
Regulatory (3004)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (15)
Series B (12)
Service/supplier (2)
Sickle cell disease (1)
Southern California (264)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (623)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
United States (2916)
Vaccines (39)
Venture capitalists (6)
Weight loss (4)
Women's health (6)
Date
Today (26)
Last 7 days (109)
Last 30 days (360)
Last 365 days (5013)
2025 (1315)
2024 (5116)
2023 (6128)
2022 (10208)
2021 (9618)
2020 (8991)
2019 (6146)
2018 (4851)
2017 (5400)
2016 (5389)
2015 (6109)
2014 (4629)
2013 (4126)
2012 (4434)
2011 (4628)
2010 (4078)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (54)
Arkansas (2)
Asia (5320)
Australia (1245)
California (711)
Canada (249)
China (30)
Colorado (49)
Connecticut (60)
Delaware (6)
Europe (15151)
Florida (94)
Georgia (37)
Idaho (4)
Illinois (93)
India (4)
Indiana (30)
Iowa (3)
Japan (21)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (93)
Massachusetts (387)
Michigan (64)
Minnesota (71)
Missouri (28)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (136)
New Mexico (17)
New York (279)
North Carolina (178)
North Dakota (6)
Northern California (328)
Ohio (28)
Oklahoma (2)
Oregon (7)
Pennsylvania (78)
Rhode Island (4)
South America (154)
South Carolina (3)
Southern California (264)
Tennessee (26)
Texas (163)
Utah (76)
Virginia (35)
Washington D.C. (6)
Washington State (65)
Wisconsin (29)
107,769 Results for "precipio diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
Specialty diagnostics company Precipio, Inc., announced that the company’s 2024 Annual Meeting of Shareholders was convened and adjourned, without any business being conducted, due to lack of the required quorum.
June 13, 2024
·
7 min read
Press Releases
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
February 26, 2025
·
6 min read
Pharm Country
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Management of specialty cancer diagnostics company Precipio, Inc. is requesting that shareholders instruct their brokers to vote their shares immediately no later than 11pm Eastern Time.
June 12, 2024
·
3 min read
Press Releases
Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs
January 17, 2025
·
4 min read
Pharm Country
Precipio Announces Year end 2023 Shareholder Update Call
Specialty cancer diagnostics company Precipio, Inc., will be hosting its year end 2023 corporate update call on April 1st, 2024 at 5:00 PM ET.
March 25, 2024
·
3 min read
Press Releases
Precipio Announces Q3-2024 Shareholder Update Call
November 7, 2024
·
3 min read
Business
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the sales and distribution of its products into the Japanese market.
January 17, 2024
·
4 min read
Business
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterResults clearly demonstrate the business’s ability to reach breakeven in the near future
Specialty cancer diagnostics company Precipio, Inc. announces that continued revenue growth generated cash levels that bring the company closer to breakeven.
January 23, 2024
·
4 min read
Business
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
Specialty cancer diagnostics company Precipio, Inc. announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products.
February 6, 2024
·
3 min read
Press Releases
Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping
October 9, 2024
·
4 min read
1 of 10,777
Next
